 |
인쇄하기
취소
|
New schizophrenia drug gets KFDA approval
The Korea Food and Drug Administration (KFDA) has approved Janssen Korea's Invega (paliperidone) extended-release tablets for treatment of schizophrenia.
A similar medication, Risperdal (risperidone), has been available for some time. However, Invega is a new molecular entity containing an active substance previously not available in Korea. Invega's effectiveness in the treatment of schizop...
A similar medication, Risperdal (risperidone), has been available for some time. However, Invega is a new molecular entity containing an active substance previously not available in Korea. Invega's effectiveness in the treatment of schizop...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.